EYEN Eyenovia Inc

Eyenovia to Present at Two Upcoming Investor Conferences

Eyenovia to Present at Two Upcoming Investor Conferences

NEW YORK, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery technology, today announced that Dr. Sean Ianchulev, Eyenovia’s Chief Executive Officer and Chief Medical Officer and John Gandolfo, Eyenovia’s Chief Financial Officer, are scheduled to present at the 21st Annual H.C. Wainwright 21st Annual Global Investment Conference being held on September 8-10, 2019 and the Ladenburg Thalmann 2019 Healthcare Conference being held on September 24, 2019 in New York.

Details for the presentations are below:

Event: H.C. Wainwright 21st Annual Global Investment Conference

Date: Tuesday, September 10, 2019

Time: 5:05 – 5:30pm ET

Location: Lotte New York Palace Hotel

Room: Kennedy I (4th Floor)

Event: Ladenburg Thalmann 2019 Healthcare Conference

Date: Tuesday, September 24, 2019

Time: 2:00 – 2:25pm ET

Location: Sofitel New York

Room: Track 5 - Montmartre

A live webcast of the Company’s presentation at the H.C. Wainwright 21st Annual Global Investment Conference may be accessed on the Company's website at . The webcast will be archived for 90 days following the live presentation on the Company's website.

Eyenovia’s management team will also be available for one-on-one meetings with investors who are registered to attend the events. Alternatively, interested investors may contact Tram Bui of The Ruth Group at  or (646) 536-7035 to schedule a meeting.

About Eyenovia

Eyenovia, Inc. (NASDAQ: EYEN) is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patent piezo-print delivery technology. Eyenovia’s pipeline is currently focused on the late-stage development of microdosed medications for mydriasis, myopia progression, glaucoma and other eye diseases. For more information please visit .

Company Contact:

Eyenovia, Inc.

John Gandolfo

Chief Financial Officer

Investor Contact:

Tram Bui / Alexander Lobo

The Ruth Group

Phone: 646-536-7035/7037

/

Media Contact:

The Ruth Group

Kirsten Thomas

508-280-6592

 

EN
03/09/2019

Underlying

EYENEyenovia Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Eyenovia Inc

 PRESS RELEASE
Free
EYEN EYENOVIA INC

Hyperion DeFi Announces Private Lending Pool Built by HyperLend

Hyperion DeFi Announces Private Lending Pool Built by HyperLend Unlocks Cost-Optimized On-Chain Credit Access, Additional Ecosystem Rewards, and Expanded Revenue Opportunities in Institutional Credit LAGUNA HILLS, Calif., March 09, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”) today announced that it has engaged with the HyperLend protocol (“HyperLend”) to create a permissioned lending pool native to the HyperEVM. Through this pool, Hyperion DeFi will utilize its HYPE Liquid Staking Token (LST), HiHYPE, as collateral to access credit on-...

March 9, 2026 1 EN
 PRESS RELEASE
Free
EYEN EYENOVIA INC

Hyperion DeFi Announces Institutional Volatility Income Vault Built on...

Hyperion DeFi Announces Institutional Volatility Income Vault Built on Rysk Protocol Productizes On-chain Strategy Designed to Enhance Yield and Ecosystem Rewards through Gated Institutional Access LAGUNA HILLS, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”) today announced that it has engaged with the Rysk protocol (“Rysk”) to launch a new institutional-grade, on-chain yield-enhancement vault native to the HyperEVM. Through this vault, Hyperion DeFi and its institutional partners will be able to utilize HYPE Liquid Staki...

February 4, 2026 1 EN
 PRESS RELEASE
Free
EYEN EYENOVIA INC

Hyperion DeFi Issues Letter to Shareholders

Hyperion DeFi Issues Letter to Shareholders LAGUNA HILLS, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”) today issued a letter to shareholders from its Chief Executive Officer, Hyunsu Jung. To the shareholders of Hyperion DeFi, Inc.: Let me start by expressing my sincere gratitude to those sharing in our journey to become the leading Hyperliquid-native Decentralized Finance (“DeFi”) company. As I formally step into the CEO role at Hyperion DeFi, I wanted to take a moment to reflect on what we’ve built in 2025 and what we l...

January 12, 2026 1 EN
 PRESS RELEASE
Free
EYEN EYENOVIA INC

Hyperion DeFi Appoints Hyunsu Jung as Chief Executive Officer

Hyperion DeFi Appoints Hyunsu Jung as Chief Executive Officer Board Confirms Leadership Team to Execute 2026 Strategic Priorities Company Also Appoints Robert Rubenstein as General Counsel LAGUNA HILLS, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”) today announced that its Board of Directors has appointed Hyunsu Jung as Chief Executive Officer, effective immediately. Mr. Jung’s appointment marks an important milestone in the Company’s leadership evolution as it advances its strategic priorities for 2026. Mr. Jung joined ...

January 5, 2026 1 EN
 PRESS RELEASE
Free
EYEN EYENOVIA INC

Hyperion DeFi Announces Receipt of Kinetiq Airdrop, Partnership with N...

Hyperion DeFi Announces Receipt of Kinetiq Airdrop, Partnership with Native Markets, and Purchase of 150,000 Additional HYPE Receives 1,918,478.78 KNTQ in the Token Generation Event Airdrop, Plus Right to Earn Additional Yield on 28,888 HYPE Staked by the Company Partnership with Native Markets to Support Hyperliquid-Aligned USDH Stablecoin Generates Additional Yield for 300,000 HYPE Staked by the Company Announces 150,000 HYPE purchase resulting in 1,862,195 Gross HYPE Tokens Owned by the Company LAGUNA HILLS, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD...

December 4, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch